Biological Drugs Market Report

Global Biological Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：160
  • REPORT CODE：GMM835876
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biological Drugs market report explains the definition, types, applications, major countries, and major players of the Biological Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Baxter

    • Abbott Laboratories

    • Biogen

    • GlaxoSmithKline

    • Novartis

    • Eli Lilly

    • Bristol-Myers Squibb

    • Shire

    • Johnson & Johnson

    • Merck

    • F Hoffmann-La Roche

    • Pfizer

    • Amgen

    By Type:

    • Therapeutic Protein

    • Monoclonal Antibody

    • Vaccine

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Biological Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Biological Drugs Outlook to 2028- Original Forecasts

    • 2.2 Biological Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Biological Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Biological Drugs Market- Recent Developments

    • 6.1 Biological Drugs Market News and Developments

    • 6.2 Biological Drugs Market Deals Landscape

    7 Biological Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Biological Drugs Key Raw Materials

    • 7.2 Biological Drugs Price Trend of Key Raw Materials

    • 7.3 Biological Drugs Key Suppliers of Raw Materials

    • 7.4 Biological Drugs Market Concentration Rate of Raw Materials

    • 7.5 Biological Drugs Cost Structure Analysis

      • 7.5.1 Biological Drugs Raw Materials Analysis

      • 7.5.2 Biological Drugs Labor Cost Analysis

      • 7.5.3 Biological Drugs Manufacturing Expenses Analysis

    8 Global Biological Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Biological Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Biological Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Biological Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Biological Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Therapeutic Protein Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biological Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Biological Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Biological Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Biological Drugs Consumption (2017-2022)

      • 10.2.2 Canada Biological Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Biological Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Biological Drugs Consumption (2017-2022)

      • 10.3.2 UK Biological Drugs Consumption (2017-2022)

      • 10.3.3 Spain Biological Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Biological Drugs Consumption (2017-2022)

      • 10.3.5 France Biological Drugs Consumption (2017-2022)

      • 10.3.6 Italy Biological Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Biological Drugs Consumption (2017-2022)

      • 10.3.8 Finland Biological Drugs Consumption (2017-2022)

      • 10.3.9 Norway Biological Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Biological Drugs Consumption (2017-2022)

      • 10.3.11 Poland Biological Drugs Consumption (2017-2022)

      • 10.3.12 Russia Biological Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Biological Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Biological Drugs Consumption (2017-2022)

      • 10.4.2 Japan Biological Drugs Consumption (2017-2022)

      • 10.4.3 India Biological Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Biological Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Biological Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Biological Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Biological Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Biological Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Biological Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Biological Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Biological Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Biological Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Biological Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Biological Drugs Consumption (2017-2022)

      • 10.5.3 Chile Biological Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Biological Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Biological Drugs Consumption (2017-2022)

      • 10.5.6 Peru Biological Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Biological Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Biological Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Biological Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Biological Drugs Consumption (2017-2022)

      • 10.6.3 Oman Biological Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Biological Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Biological Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Biological Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Biological Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Biological Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Biological Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Biological Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Biological Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Biological Drugs Consumption (2017-2022)

    11 Global Biological Drugs Competitive Analysis

    • 11.1 Baxter

      • 11.1.1 Baxter Company Details

      • 11.1.2 Baxter Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Baxter Biological Drugs Main Business and Markets Served

      • 11.1.4 Baxter Biological Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Abbott Laboratories

      • 11.2.1 Abbott Laboratories Company Details

      • 11.2.2 Abbott Laboratories Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Abbott Laboratories Biological Drugs Main Business and Markets Served

      • 11.2.4 Abbott Laboratories Biological Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Biogen

      • 11.3.1 Biogen Company Details

      • 11.3.2 Biogen Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Biogen Biological Drugs Main Business and Markets Served

      • 11.3.4 Biogen Biological Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 GlaxoSmithKline

      • 11.4.1 GlaxoSmithKline Company Details

      • 11.4.2 GlaxoSmithKline Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 GlaxoSmithKline Biological Drugs Main Business and Markets Served

      • 11.4.4 GlaxoSmithKline Biological Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Biological Drugs Main Business and Markets Served

      • 11.5.4 Novartis Biological Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Eli Lilly

      • 11.6.1 Eli Lilly Company Details

      • 11.6.2 Eli Lilly Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Eli Lilly Biological Drugs Main Business and Markets Served

      • 11.6.4 Eli Lilly Biological Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bristol-Myers Squibb

      • 11.7.1 Bristol-Myers Squibb Company Details

      • 11.7.2 Bristol-Myers Squibb Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bristol-Myers Squibb Biological Drugs Main Business and Markets Served

      • 11.7.4 Bristol-Myers Squibb Biological Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Shire

      • 11.8.1 Shire Company Details

      • 11.8.2 Shire Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Shire Biological Drugs Main Business and Markets Served

      • 11.8.4 Shire Biological Drugs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Johnson & Johnson

      • 11.9.1 Johnson & Johnson Company Details

      • 11.9.2 Johnson & Johnson Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Johnson & Johnson Biological Drugs Main Business and Markets Served

      • 11.9.4 Johnson & Johnson Biological Drugs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Merck

      • 11.10.1 Merck Company Details

      • 11.10.2 Merck Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Merck Biological Drugs Main Business and Markets Served

      • 11.10.4 Merck Biological Drugs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 F Hoffmann-La Roche

      • 11.11.1 F Hoffmann-La Roche Company Details

      • 11.11.2 F Hoffmann-La Roche Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 F Hoffmann-La Roche Biological Drugs Main Business and Markets Served

      • 11.11.4 F Hoffmann-La Roche Biological Drugs Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Pfizer

      • 11.12.1 Pfizer Company Details

      • 11.12.2 Pfizer Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Pfizer Biological Drugs Main Business and Markets Served

      • 11.12.4 Pfizer Biological Drugs Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Amgen

      • 11.13.1 Amgen Company Details

      • 11.13.2 Amgen Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Amgen Biological Drugs Main Business and Markets Served

      • 11.13.4 Amgen Biological Drugs Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Biological Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Biological Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Therapeutic Protein Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Biological Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Biological Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Biological Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Biological Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Biological Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Biological Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Biological Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Biological Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Biological Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Biological Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Biological Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Biological Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Biological Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Biological Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Biological Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Biological Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Biological Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Biological Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Biological Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Biological Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Biological Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Biological Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Biological Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Biological Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Biological Drugs

    • Figure of Biological Drugs Picture

    • Table Global Biological Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Biological Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Therapeutic Protein Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Biological Drugs Consumption by Country (2017-2022)

    • Table North America Biological Drugs Consumption by Country (2017-2022)

    • Figure United States Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Biological Drugs Consumption by Country (2017-2022)

    • Figure Germany Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Biological Drugs Consumption by Country (2017-2022)

    • Figure China Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Biological Drugs Consumption by Country (2017-2022)

    • Figure Brazil Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Biological Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Biological Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Biological Drugs Consumption by Country (2017-2022)

    • Figure Australia Biological Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Biological Drugs Consumption and Growth Rate (2017-2022)

    • Table Baxter Company Details

    • Table Baxter Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Biological Drugs Main Business and Markets Served

    • Table Baxter Biological Drugs Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Biological Drugs Main Business and Markets Served

    • Table Abbott Laboratories Biological Drugs Product Portfolio

    • Table Biogen Company Details

    • Table Biogen Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Biological Drugs Main Business and Markets Served

    • Table Biogen Biological Drugs Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Biological Drugs Main Business and Markets Served

    • Table GlaxoSmithKline Biological Drugs Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Biological Drugs Main Business and Markets Served

    • Table Novartis Biological Drugs Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Biological Drugs Main Business and Markets Served

    • Table Eli Lilly Biological Drugs Product Portfolio

    • Table Bristol-Myers Squibb Company Details

    • Table Bristol-Myers Squibb Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Biological Drugs Main Business and Markets Served

    • Table Bristol-Myers Squibb Biological Drugs Product Portfolio

    • Table Shire Company Details

    • Table Shire Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Biological Drugs Main Business and Markets Served

    • Table Shire Biological Drugs Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Biological Drugs Main Business and Markets Served

    • Table Johnson & Johnson Biological Drugs Product Portfolio

    • Table Merck Company Details

    • Table Merck Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Biological Drugs Main Business and Markets Served

    • Table Merck Biological Drugs Product Portfolio

    • Table F Hoffmann-La Roche Company Details

    • Table F Hoffmann-La Roche Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Biological Drugs Main Business and Markets Served

    • Table F Hoffmann-La Roche Biological Drugs Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Biological Drugs Main Business and Markets Served

    • Table Pfizer Biological Drugs Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Biological Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Biological Drugs Main Business and Markets Served

    • Table Amgen Biological Drugs Product Portfolio

    • Figure Global Therapeutic Protein Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biological Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Biological Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Biological Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US